Meril Group: Advancing Precision, Accessibility, And Innovation In Orthopaedics And Minimally Invasive Surgery

Vivek Shah, CEO

Vivek Shah

CEO

In the evolving landscape of global healthcare, manufac­turers and suppliers in pain management and orthopae­dics are playing an increasingly critical role in redefining treatment outcomes. No longer limited to delivering medical devices, these organizations are now expected to drive inno­vation that enhances surgical precision, minimizes patient trauma, and accelerates recovery. The industry is witnessing a shift toward minimally invasive techniques, patient-cen­tric solutions, and technology-enabled care, where success is measured not only by clinical efficacy but also by quality of life post-treatment. As demand for advanced yet accessible solutions grows, companies that combine research, scalabil­ity, and clinical collaboration are setting new benchmarks in orthopaedic and pain management care.

Among the organizations leading this transformation is Meril Group, a globally recognized medtech company head­quartered in Vapi, Gujarat. By integrating advanced engineer­ing with clinical insights, Meril has positioned itself as a key contributor to the evolution of orthopaedic care, particularly in joint reconstruction and minimally invasive surgical solu­tions. The company’s approach focuses not only on devel­oping high-quality products but also on ensuring that these innovations translate into improved patient outcomes across diverse healthcare settings.

A Global Medtech Powerhouse Built on Pur­pose

Meril Group has established a formidable global presence, op­erating in over 150 countries with more than 40 subsidiaries and a workforce exceeding 15,000 professionals. Its expan­sive portfolio spans orthopaedics, cardiovascular care, en­do-surgery, diagnostics, and surgical robotics. At the heart of its operations lies a clear mission: to make advanced health­care solutions both innovative and accessible.

The company’s manufacturing capabilities and research infrastructure are designed to meet global quality standards, enabling it to compete with established international players while maintaining cost efficiency. This balance between ac­cessibility and innovation has been instrumental in expand­ing access to high-quality medical devices, particularly in emerging markets where affordability often dictates treat­ment options.

Transforming Orthopaedic Care through Pre­cision and Personalization

Meril’s orthopaedics division represents one of its strongest pillars, offering comprehensive solutions for joint replace­ment and trauma management. The company addresses a wide spectrum of patient needs, ranging from sports-related injuries in younger populations to degenerative joint condi­tions in the elderly.

A significant focus lies in its joint reconstruction plat­form, which includes advanced knee and hip implants devel­oped through rigorous biomechanical research and close col­laboration with surgeons. These implants are crafted from biocompatible materials and are available in multiple sizes and configurations, allowing for a more personalized fit. This adaptability ensures that surgical interventions are tailored to individual anatomical and clinical requirements, ultimate­ly improving stability, mobility, and long-term outcomes.

“By emphasizing precision-driven care, Meril is contrib­uting to a shift where orthopaedic success is defined not just by the procedure itself, but by how effectively patients regain their independence and return to everyday activities”, shares Vivek Shah, CEO, Meril Group

MISSO: Redefining Minimally Invasive Ortho­paedics

One of Meril’s most transformative contributions is its MISSO surgical robot, which represents a comprehensive approach to minimally invasive orthopaedic surgery. Rather than be­ing a standalone product, MISSO integrates specialized in­struments, implants, imaging compatibility, and structured surgeon training.

This approach enables surgeons to perform complex joint procedures through smaller incisions, significantly reducing damage to muscles and surrounding tissues. The result is a surgical experience that is less taxing on the body, leading to reduced pain, shorter hospital stays, and faster recovery times. Advanced instrumentation and real-time imaging fur­ther enhance surgical precision, ensuring optimal outcomes with minimal disruption.

One of Meril’s most transformative contributions is its MISSO robot, which represents a comprehensive approach to minimally invasive orthopaedic surgery

Vivek Shah, CEO

For patients, MISSO translates into tangible benefits: quicker rehabilitation, lower risk of complications, and an earlier return to normal life. For healthcare providers, it rep­resents a step forward in delivering efficient, high-quality care aligned with modern clinical expectations.

Bridging Innovation and Practice through Education

A defining strength of Meril lies in its commitment to clinical education, primarily through the Meril Academy. Recogniz­ing that innovation is only as effective as its adoption, the company invests heavily in training healthcare professionals to safely and effectively utilize advanced technologies.

The Academy offers structured programs, including simulation-based learning, hands-on workshops, cadaveric training, and live surgical demonstrations. Collaborations with leading medical institutions further strengthen these initiatives, ensuring that surgeons are well-equipped to adopt evolving techniques such as minimally invasive proce­dures.

Importantly, Meril’s educational outreach extends be­yond metropolitan centers, reaching tier-2 and tier-3 cities. This democratization of knowledge ensures that advanced orthopaedic care is not confined to urban hospitals but is ac­cessible to a broader patient population.

Driving Inclusive and Patient-Centric Health­care

Beyond technological advancements, Meril actively promotes awareness and responsible healthcare practices through initiatives like ‘Treatment Zaroori Hai.’ This campaign em­phasizes the importance of timely medical intervention, ad­dressing common barriers such as fear, misinformation, and neglect of symptoms.

By encouraging early diagnosis and treatment, the initia­tive highlights the broader impact of proactive healthcare - not only improving individual well-being but also reducing the burden on families and caregivers. This patient-centric philosophy aligns with Meril’s broader vision of creating a healthcare ecosystem where innovation, education, and awareness work in tandem.

As India’s orthopaedic device market continues to evolve, Meril is further strengthening its focus on emerging tech­nologies such as robotics-assisted surgery, digital surgical planning, and advanced biomaterials. These efforts under­score its commitment to shaping the future of orthopaedics through research-driven innovation.

With a clear vision and a strong foundation, Meril Group continues to push the boundaries of what is possible in or­thopaedics and minimally invasive surgery, ensuring that progress in healthcare is not only advanced but also inclu­sive, precise, and deeply patient-focused.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.